Drawing for AORTIC CONFIGURATOR

USPTO serial 98809155

AORTIC CONFIGURATOR

Reviewed by CopyMark Law Group

Reg. 7942526Status 700Registered
Filing date
Status date
Registration date
Sep 9, 2025
Examiner
HUTCHISON, DAVID A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AORTIC CONFIGURATOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Megan E. Fink

Megan E. Fink Bodman PLC201 South Division Street, Suite 400Ann Arbor, MI 48104United States

Goods and services

ClassDescriptionStatusFirst use
009Computer software applications, recorded or downloadable for configuring a customized surgical, endovascular, and/or hybrid medical device for the aorta; Computer software applications, recorded or downloadable, for displaying medical device products used to treat cardiovascular disease, and to enable physicians or healthcare providers in the field of cardiovascular medicine to search and view medical device products; Downloadable computer databases in the fields of health care management, clinical data analytics, and medical device products to treat cardiovascular diseaseACTIVE—
035Arranging of managed care contractual services in the fields of screening and diagnostics for home health care, preventive care, care before, during and after hospitalization in the field of cardiovascular disease; Commercial information; Providing commercial information in the field of medical device products used to treat cardiovascular disease; Providing consumer product information and advice; Providing consumer product information regarding medical devices for treating cardiovascular disease; Providing information in the field of medical appointment reminders and scheduling; Medical appointment reminder services; Medical appointment scheduling services; Information, advisory and consultancy services in relation to all of the aforementioned servicesACTIVE—
042Computer services, namely, providing search engines for obtaining data on a global computer network; Providing search engines for the internet; Providing search engines for the internet, namely, providing search engines for physicians and healthcare providers to search for products and information in the field of cardiovascular medicine; Software as a service (SaaS) services featuring software for configuring a customized surgical, endovascular, and/or hybrid medical device for the aorta; Software as a service (SaaS) services featuring software for storing, searching, and retrieving information regarding health care management, clinical data analytics, and medical device products used to treat cardiovascular disease, for scheduling appointments and sending and receiving appointment reminders, and for accessing information and advice related to medical services, health care management, in-home heath care, health resources, health reports, clinical assessments, medical consultation for the treatment and prevention of cardiovascular disease, and medical device products used to treat cardiovascular disease; Information, advisory and consultancy services in relation to all of the aforementioned servicesACTIVE—
044Medical services; Providing an online searchable database for storing, searching and retrieving information regarding health care management, clinical data analytics, and medical device products used to treat cardiovascular disease; Providing information related to medical services, health care management, in-home health care, health resources, health reports, clinical assessments and medical consultation for the treatment and prevention of cardiovascular disease;Medical consultation services in the field of cardiovascular disease; Managed healthcare services; Managed care services, namely, electronic processing of health care information in the field of cardiovascular disease; Information, advisory and consultancy services in relation to all of the aforementioned servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 20, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 20, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 20, 2026EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Mar 20, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 20, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 20, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 20, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 9, 2025NRCSNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 9, 2025R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Aug 5, 2025CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Aug 5, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Aug 5, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 5, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 5, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 30, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jul 30, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 30, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 30, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 30, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jul 30, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 30, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 30, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 29, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 29, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 29, 2025ALIEASSIGNED TO LIE—
Jul 21, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 22, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2025DOCKASSIGNED TO EXAMINER—
Apr 20, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 18, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance